X4 Pharmaceuticals Inc

NASDAQ:XFOR   3:59:52 PM EDT
1.22
-0.08 (-6.54%)
Earnings Announcements

X4 Pharmaceuticals Reports First Quarter 2022 Financial Results And Provides Corporate Update

Published: 05/12/2022 10:22 GMT
X4 Pharmaceuticals Inc (XFOR) - X4 Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update.
Clinical and Regulatory Updates From Ongoing Chronic Neutropenia Phase 1b Study Anticipated During 3q 2022.
Expects That Its Cash and Cash Equivalents Will Fund Company Operations Into Q4 of 2022.
Qtrly Loss per Share $0.72.
Q1 Earnings per Share View $-0.61 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.63

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.56

More details on our Analysts Page.